Profile data is unavailable for this security.
About the company
Nfl Biosciences SAS is a France-based company which provides botanical pharmaceutical services. The Company's products help cure addictions through an approach based on botanical pharmaceutical agents. It develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The Company applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.
- Revenue in EUR (TTM)0.00
- Net income in EUR-3.75m
- Incorporated2006
- Employees3.00
- LocationNfl Biosciences SAS199 rue Helene BoucherCASTELNAU-LE-LEZ 34170FranceFRA
- Phone+33 411937667
- Fax+33 411937667
- Websitehttps://www.nflbiosciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theranexus SA | 0.00 | -6.83m | 4.66m | 19.00 | -- | 2.10 | -- | -- | -1.09 | -1.09 | 0.00 | 0.2863 | 0.00 | -- | -- | 0.00 | -70.79 | -42.66 | -82.29 | -47.97 | -- | -- | -- | -- | -- | -1,058.68 | 0.6212 | -- | -- | -- | -3.97 | -- | -33.23 | -- |
| Acticor Biotech SA | 0.00 | -18.64m | 5.36m | 28.00 | -- | -- | -- | -- | -1.55 | -1.55 | 0.00 | -0.4028 | 0.00 | -- | -- | 0.00 | -164.53 | -- | -568.29 | -- | -- | -- | -- | -- | -- | -19.85 | 10.47 | -- | -- | -- | -17.40 | -- | -- | -- |
| Plant Advanced Technologies PAT SA | 1.68m | 79.16k | 16.37m | 27.00 | 202.90 | 1.90 | 28.24 | 9.74 | 0.0725 | 0.0725 | 1.54 | 7.73 | 0.1118 | -0.4123 | 1.60 | 62,278.52 | 0.5262 | -3.53 | 0.6534 | -4.39 | 128.03 | 134.21 | 4.71 | -33.16 | 0.4183 | -15.32 | 0.3402 | -- | 8.56 | 8.05 | 119.67 | -38.00 | -- | -- |
| Phaxiam Therapeutics SA | 1.33m | -23.49m | 16.65m | 51.00 | -- | 0.4281 | -- | 12.55 | -5.14 | -5.14 | 0.2901 | 3.90 | 0.0273 | -- | 14.82 | 26,000.00 | -48.37 | -50.69 | -66.94 | -66.25 | -- | -- | -1,771.42 | -1,009.09 | -- | -70.21 | 0.3412 | -- | -80.05 | -21.50 | -10,201.75 | -- | -56.68 | -- |
| Oncodesign Precision Medicine Opm SA | 1.07m | -8.09m | 18.19m | 22.00 | -- | 4.51 | -- | 16.97 | -0.4863 | -0.4863 | 0.0645 | 0.2219 | 0.0613 | -- | 1.39 | 48,735.00 | -46.23 | -- | -63.87 | -- | 130.48 | -- | -754.61 | -- | -- | -- | 0.7052 | -- | -86.57 | -- | -3,399.73 | -- | -- | -- |
| Predilife SA | 317.79k | -4.22m | 18.54m | 19.00 | -- | -- | -- | 58.33 | -1.14 | -1.14 | 0.0858 | -1.06 | 0.0695 | -- | 2.05 | 17,030.55 | -92.43 | -89.36 | -129.39 | -123.81 | 97.25 | 83.94 | -1,329.21 | -1,901.22 | -- | -6.23 | 2.20 | -- | 10.11 | 79.85 | -15.58 | -- | -18.51 | -- |
| Nfl Biosciences SAS | 0.00 | -3.75m | 19.41m | 3.00 | -- | 10.52 | -- | -- | -0.4674 | -0.4674 | 0.00 | 0.1901 | 0.00 | -- | -- | 0.00 | -117.67 | -83.27 | -292.70 | -122.37 | -- | -- | -- | -- | -- | -- | 0.0388 | -- | -- | -- | -53.28 | -- | -- | -- |
| Valbiotis SA | 4.73m | -7.37m | 21.39m | 52.00 | -- | 1.09 | -- | 4.52 | -0.5904 | -0.5904 | 0.3798 | 1.24 | 0.1564 | 3.36 | 17.83 | 91,019.23 | -24.35 | -32.92 | -33.77 | -46.36 | 48.76 | 53.15 | -155.67 | -418.87 | 3.38 | -38.19 | 0.2598 | -- | 502.93 | 126.73 | 40.16 | -- | -21.71 | -- |
| Poxel SA | 1.55m | -44.24m | 29.37m | 30.00 | -- | -- | -- | 19.00 | -1.44 | -1.44 | 0.0507 | -1.22 | 0.0597 | -- | 5.42 | 30,920.00 | -170.71 | -31.97 | -432.50 | -55.94 | 0.1294 | -- | -2,861.58 | -101.47 | -- | -4.08 | 11.28 | -- | -94.97 | -33.77 | -32.13 | -- | -8.49 | -- |
| Fermentalg SA | 4.06m | -14.15m | 34.12m | 62.00 | -- | 0.6565 | -- | 8.41 | -0.3176 | -0.3176 | 0.0917 | 0.6033 | 0.0753 | 0.533 | 3.35 | 65,451.61 | -24.63 | -21.94 | -26.79 | -24.71 | 13.21 | 14.73 | -327.08 | -248.95 | 3.53 | -60.94 | 0.3323 | -- | -46.94 | 75.18 | -43.29 | -- | -10.93 | -- |
| genOway SA | 20.05m | 1.57m | 35.24m | 133.00 | 21.33 | 2.03 | 8.78 | 1.76 | 0.1782 | 0.1782 | 2.28 | 1.88 | 0.619 | 0.773 | 3.10 | 150,724.70 | 4.84 | 0.2166 | 6.64 | 0.3048 | 95.82 | 94.82 | 7.82 | 0.4177 | 1.95 | 28.11 | 0.3047 | -- | 17.55 | 13.16 | 101.55 | 22.35 | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Nfl Biosciences SAS's reporting currency: Euro EUR
0.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Friedland Gestion SASas of 31 May 2024 | 27.01k | 0.28% |
Data from 31 May 2024 - 31 May 2024Source: FactSet Research Systems Inc.
